首頁 > 市場調查報告書 > 醫療設備

過敏診斷市場規模、佔有率和成長分析（按產品/服務、檢測方法、過敏原、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1895879

過敏診斷市場規模、佔有率和成長分析（按產品/服務、檢測方法、過敏原、最終用戶和地區分類）－2026-2033年產業預測

Allergy Diagnostics Market Size, Share, and Growth Analysis, By Product (Assay Kits, Instruments), By Tests (In-vivo Tests, In-vitro Tests), By Allergen, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月15日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球過敏診斷市場規模預計在 2024 年達到 48 億美元，從 2025 年的 53.3 億美元成長到 2033 年的 122.8 億美元，在預測期（2026-2033 年）內複合年成長率為 11%。

全球過敏診斷市場正經歷顯著成長，這主要得益於過敏性疾病的增加、診斷技術的進步以及公眾對過敏檢測意識的提高。常見的過敏性疾病，例如花粉症、氣喘和食物過敏，由於各種環境和生活方式因素的影響而日益增加。皮膚點刺試驗、體外檢測和分子診斷等創新技術正在提高該領域的準確性和效率。然而，監管壁壘、先進診斷方法的高成本以及缺乏標準化等挑戰可能會阻礙市場擴張。儘管存在這些障礙，但新興的創新診斷方法、機器學習和人工智慧的整合以及醫療基礎設施投資的不斷增加，為過敏診斷領域的未來成長提供了巨大的機會。

推動全球過敏診斷市場發展的因素

個人化醫療的興起正對過敏診斷市場產生重大影響。人們對能夠全面了解個別過敏原易感性的過敏檢測的需求日益成長，從而能夠制定更個人化的治療方案。專注於識別與過敏相關的特定生物標記的研發進展，正在提升制定個人化治療策略的能力，進一步推動過敏診斷領域的發展。隨著醫療保健朝著更個人化的方向發展，過敏診斷和治療的準確性變得愈發重要，這將最終塑造過敏診斷的未來格局。

全球過敏診斷市場面臨的限制因素

全球過敏診斷市場的成長正受到家用檢測套組和自我診斷方法日益普及的阻礙。雖然這些家用過敏檢測方案為患者提供了便利，但與檢查室診斷相比，其準確性往往不足。這種偏好的轉變可能導致對專業檢測服務的需求下降，最終影響市場擴張。此外，患者傾向於嘗試DIY方法和家庭療法，這進一步削弱了傳統過敏診斷產業。因此，對低準確性家用檢測方案的依賴對整體市場發展構成了顯著挑戰。

全球過敏診斷市場趨勢

全球過敏診斷市場的一個顯著趨勢是分子診斷技術的日益普及，包括過敏原成分檢測和次世代定序等先進技術。這些技術提高了分子層面過敏原檢測的準確性，從而能夠根據患者的個別敏感性制定高度個人化的治療方案。隨著醫療機構認知到精準診斷的價值，提供個人化治療的能力有望顯著改善患者的治療效果。此外，ELISA、PCR 和 NHS 等調查方法的廣泛應用也進一步推動了市場的發展，有助於實現更精細、更有效的過敏管理方法。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific Inc.（US）
Siemens Healthineers AG（Germany）
Danaher（US）
Canon Inc.（Minaris Medical America, Inc.）（Japan/US）
Eurofins Scientific（Luxembourg）
EUROIMMUN Medizinische Labordiagnostika AG（Revvity Inc.）（Germany/US）
bioMerieux SA（France）
Stallergenes Greer Ltd.（UK）
HollisterStier Allergy（US）
Omega Diagnostics Group PLC（UK）
R-Biopharm AG（Germany）
HYCOR Biomedical（US）
Lincoln Diagnostics, Inc.（US）
HOB Biotech Group Corp., Ltd.（China）
Romer Labs Division Holding GmbH（Austria）
AESKU.GROUP GmbH（Germany）
Neogen Corporation（US）
ALK-Abello A/S（Denmark）
Abbott Laboratories（US）
Phadia（part of Thermo Fisher Scientific）（Sweden/US）

結論與建議

簡介目錄

Product Code: SQSG35I2040

Global Allergy Diagnostics Market size was valued at USD 4.80 Billion in 2024 and is poised to grow from USD 5.33 Billion in 2025 to USD 12.28 Billion by 2033, growing at a CAGR of 11% during the forecast period (2026-2033).

The global allergy diagnostics market is experiencing significant growth driven by the increasing prevalence of allergic conditions, advancements in diagnostic technologies, and heightened public awareness surrounding allergy testing. Common allergic disorders, including hay fever, asthma, and food allergies, are on the rise, attributable to various environmental and lifestyle factors. Innovations such as skin prick tests, in vitro testing, and molecular diagnostics are enhancing accuracy and efficiency within the sector. However, challenges such as regulatory hurdles, high costs of advanced diagnostics, and a lack of standardization may hinder market expansion. Despite these obstacles, emerging innovative diagnostic methods, the integration of machine learning and artificial intelligence, along with increased investment in healthcare infrastructure, present considerable opportunities for future growth within the allergy diagnostics landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Allergy Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Allergy Diagnostics Market Segments Analysis

Global Allergy Diagnostics Market is segmented by Product, Tests, Allergen, End User and region. Based on Product, the market is segmented into Assay Kits, Instruments, Services and Consumables. Based on Tests, the market is segmented into In-vivo Tests and In-vitro Tests. Based on Allergen, the market is segmented into Inhaled Allergens, Food Allergens, Drug Allergens and Other Allergens. Based on End User, the market is segmented into Diagnostic Laboratories, Hospital-Based Laboratories, Academic Research Institutes and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Allergy Diagnostics Market

The growing trend towards personalized medicine is significantly influencing the allergy diagnostics market. There is a rising demand for allergy testing that provides comprehensive insights into individual sensitivities, facilitating more tailored treatment options. Advances in research focused on identifying specific biomarkers linked to allergies enhance the capacity to develop customized treatment strategies, further propelling the growth of the allergy diagnostics sector. As healthcare moves towards more individualized approaches, the emphasis on precision in diagnosing and treating allergies is becoming increasingly crucial, ultimately shaping the future landscape of allergy diagnostics.

Restraints in the Global Allergy Diagnostics Market

The growth of the global allergy diagnostics market is being hindered by the increasing popularity of home testing kits and do-it-yourself approaches. While these home-based allergy testing solutions provide greater convenience for patients, they often lack the accuracy of laboratory-based diagnostics. This shift in preference can lead to a decline in the demand for professional testing services, ultimately impacting market expansion. Additionally, the tendency for patients to explore DIY methods and home remedies further detracts from the traditional allergy diagnostics industry. Consequently, reliance on less precise home testing options poses a notable challenge to overall market development.

Market Trends of the Global Allergy Diagnostics Market

The Global Allergy Diagnostics market is witnessing a significant trend towards the increased adoption of molecular diagnostics, which includes advanced techniques such as allergen component testing and next-generation sequencing. These technologies enhance the accuracy of allergen detection at the molecular level, leading to highly personalized treatment plans based on individual patient sensitivities. As healthcare providers recognize the value of precision diagnostics, the ability to deliver tailored therapies is expected to improve patient outcomes considerably. Additionally, the prevalent use of methodologies like ELISA, PCR, and NHS further fuels the market's evolution, contributing to a more sophisticated and effective approach to allergy management.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis

Global Allergy Diagnostics Market Size by Product & Services & CAGR (2026-2033)

Market Overview
Assay Kits
Instruments
Services
Consumables

Global Allergy Diagnostics Market Size by Tests & CAGR (2026-2033)

Market Overview
In-vivo Tests
In-vitro Tests

Global Allergy Diagnostics Market Size by Allergen & CAGR (2026-2033)

Market Overview
Inhaled Allergens
Food Allergens
Drug Allergens
Other Allergens

Global Allergy Diagnostics Market Size by End User & CAGR (2026-2033)

Market Overview
Diagnostic Laboratories
Hospital-Based Laboratories
Academic Research Institutes
Other End Users

Global Allergy Diagnostics Market Size & CAGR (2026-2033)

North America (Product & Services, Tests, Allergen, End User)
- US
- Canada
Europe (Product & Services, Tests, Allergen, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product & Services, Tests, Allergen, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product & Services, Tests, Allergen, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product & Services, Tests, Allergen, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Inc. (Minaris Medical America, Inc.) (Japan/US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EUROIMMUN Medizinische Labordiagnostika AG (Revvity Inc.) (Germany/US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stallergenes Greer Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HollisterStier Allergy (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Diagnostics Group PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
R-Biopharm AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HYCOR Biomedical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lincoln Diagnostics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HOB Biotech Group Corp., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Romer Labs Division Holding GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AESKU.GROUP GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ALK-Abello A/S (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phadia (part of Thermo Fisher Scientific) (Sweden/US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments